Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.04%33.99M | 18.98%137.7M | 16.26%36.3M | -0.56%30.55M | 20.72%35.06M | 44.66%35.8M | 3.21%115.73M | -9.40%31.23M | 18.27%30.72M | 29.04M |
| Cost of revenue | 12.03%83.6M | -4.15%74.63M | ||||||||
| Gross profit | 31.62%54.1M | 19.92%41.1M | ||||||||
| Operating expense | 7.56%18.76M | 24.97%17.44M | ||||||||
| Selling and administrative expenses | ---- | 6.70%22.35M | ---- | ---- | ---- | ---- | 21.27%20.95M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | 21.89%1.58M | ---- | ---- | ---- | ---- | 18.16%1.3M | ---- | ---- | ---- |
| -General and administrative expense | ---- | 5.70%20.77M | ---- | ---- | ---- | ---- | 21.48%19.65M | ---- | ---- | ---- |
| Other operating expenses | ---- | -5.54%344.68K | ---- | ---- | ---- | ---- | -9.37%364.89K | ---- | ---- | ---- |
| Total other operating income | ---- | 1.69%3.94M | ---- | ---- | ---- | ---- | 4.06%3.88M | ---- | ---- | ---- |
| Operating profit | 12.68%8.66M | 49.34%35.34M | 59.16%11.7M | -10.02%5.79M | 78.64%10.11M | 89.66%7.68M | 16.44%23.67M | 14.92%7.35M | 18.16%6.43M | 6.61%5.66M |
| Net non-operating interest income (expenses) | 59.69%-608.41K | 17.45%-1.51M | ||||||||
| Non-operating interest income | 59.44%574K | 87.22%1.98M | 95.24%615K | 87.95%577K | 79.25%432K | 81.82%360K | 159.61%1.06M | 138.33%315K | 162.39%307K | 183.53%241K |
| Non-operating interest expense | -5.49%620K | 0.90%2.59M | -7.85%646K | 2.09%636K | 3.49%653K | 6.67%656K | 14.86%2.57M | 18.65%701K | 7.79%623K | 13.29%631K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 65.87%-58.49K | -30.28%-171.37K | ||||||||
| Less:Write off | ---- | -65.87%58.49K | ---- | ---- | ---- | ---- | 30.28%171.37K | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 16.57%8.61M | 57.73%34.68M | 67.54%11.67M | -6.33%5.73M | 87.67%9.89M | 103.27%7.39M | 19.72%21.98M | 19.96%6.97M | 22.75%6.11M | 8.95%5.27M |
| Income tax | 49.72%2.17M | 58.08%8.88M | 161.19%1.49M | -49.17%1.14M | 153.27%4.8M | 59.08%1.45M | 66.69%5.61M | -33.29%572K | 20.35%2.24M | 393.23%1.89M |
| Net income | 8.50%6.45M | 57.61%25.8M | 59.16%10.18M | 18.46%4.59M | 50.87%5.1M | 118.02%5.94M | 9.17%16.37M | 29.18%6.39M | 24.17%3.87M | -24.18%3.38M |
| Net income continuous operations | 8.50%6.45M | 57.61%25.8M | 59.16%10.18M | 18.46%4.59M | 50.87%5.1M | 118.02%5.94M | 9.17%16.37M | 29.18%6.39M | 24.17%3.87M | -24.18%3.38M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 8.50%6.45M | 57.61%25.8M | 59.16%10.18M | 18.46%4.59M | 50.87%5.1M | 118.02%5.94M | 9.17%16.37M | 29.18%6.39M | 24.17%3.87M | -24.18%3.38M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 8.50%6.45M | 57.61%25.8M | 59.16%10.18M | 18.46%4.59M | 50.87%5.1M | 118.02%5.94M | 9.17%16.37M | 29.18%6.39M | 24.17%3.87M | -24.18%3.38M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -24.60%0.0331 | 29.52%0.1606 | 8.06%0.0523 | -9.56%0.0265 | 66.41%0.0426 | 113.11%0.0439 | 9.15%0.124 | 29.07%0.0484 | 24.15%0.0293 | -24.04%0.0256 |
| Diluted earnings per share | -6.76%0.0331 | 43.91%0.1606 | 24.82%0.0523 | 0.76%0.0265 | 38.29%0.0307 | 72.33%0.0355 | -1.76%0.1116 | 11.74%0.0419 | 11.44%0.0263 | -34.12%0.0222 |
| Dividend per share | 0.025 | 0.04 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.